PDCD1 and Sepsis: To determine whether increased survival and reduced bacterial burden in PD1 peptide antagonist-treated mice was associated with relief from sepsis-induced dysfunction, peritoneal macrophages were isolated and their ex vivo phagocytic capacity was assessed in an in vitro assay system in which fluorescein-conjugated E. coli were incubated with the macrophages.